Differential effects of growth factors on oligodendrocyte progenitor migration

European Journal of Cell Biology

Volumn 90, Issue 8, 2011, Pages 649-656

  Vora, Parvez ^a   Pillai, Prakash P ^a   Zhu, Wenjun ^a   Mustapha, Joumana ^a   Namaka, Michael P ^a   Frost, Emma E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

ERK; FGF2; Migration; Oligodendrocyte progenitor; PDGF A

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PLATELET DERIVED GROWTH FACTOR A; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ARTICLE; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL MIGRATION; ENZYME ACTIVATION; NONHUMAN; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; BLOTTING, WESTERN; BRAIN; BUTADIENES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; MAP KINASE KINASE 1; MAP KINASE KINASE 2; NITRILES; OLIGODENDROGLIA; PLATELET-DERIVED GROWTH FACTOR; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 79957741613     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.03.006     Document Type: Article

References (75)

1. Armstrong R., Harvath L., Dubois-Dalcq M. Astrocytes and O-2A progenitors migrate toward distinct molecules in a microchemotaxis chamber. Ann. N. Y. Acad. Sci. 1991, 633:520-522.
2. Armstrong R.C., Harvath L., Dubois-Dalcq M.E. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J. Neurosci. Res. 1990, 27:400-407.
3. Armstrong R.C. Isolation and characterization of immature oligodendrocyte lineage cells. Methods 1998, 16:282-292.
4. Armstrong R.C., Le T.Q., Frost E.E., Borke R.C., Vana A.C. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J. Neurosci. 2002, 22:8574-8585.
5. Avrov K., Kazlauskas A. The role of c-Src in platelet-derived growth factor alpha receptor internalization. Exp. Cell. Res. 2003, 291:426-434.
6. Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J., Kinney H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci. 2001, 21:1302-1312.
7. Bansal R., Kumar M., Murray K., Morrison R.S., Pfeiffer S.E. Regulation of FGF receptors in the oligodendrocyte lineage. Mol. Cell. Neurosci. 1996, 7:263-275.
8. Bansal R., Lakhina V., Remedios R., Tole S. Expression of FGF receptors 1, 2, 3 in the embryonic and postnatal mouse brain compared with Pdgfralpha, Olig2 and Plp/dm20: implications for oligodendrocyte development. Dev. Neurosci. 2003, 25:83-95.
9. Bansal R., Magge S., Winkler S. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. J. Neurosci. Res. 2003, 74:486-493.
10. Baron W., Metz B., Bansal R., Hoekstra D., de Vries H. PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol. Cell. Neurosci. 2000, 15:314-329.
11. Baron W., Shattil S.J., Ffrench-Constant C. The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alphav beta3 integrins. EMBO J. 2002, 21:1957-1966.
12. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992, 70:31-46.
13. Bogler O., Wren D., Barnett S.C., Land H., Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:6368-6372.
14. Bottenstein J.E., Sato G.H. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:514-517.
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
16. Brunmark C., Runstrom A., Ohlsson L., Sparre B., Brodin T., Astrom M., Hedlund G. The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2002, 130:163-172.
17. Calver A.R., Hall A.C., Yu W.P., Walsh F.S., Heath J.K., Betsholtz C., Richardson W.D. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 1998, 20:869-882.
18. Canoll P.D., Musacchio J.M., Hardy R., Reynolds R., Marchionni M.A., Salzer J.L. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 1996, 17:229-243.
19. Claesson-Welsh L. Signal transduction by the PDGF receptors. Prog. Growth Factor Res. 1994, 5:37-54.
20. Ebner S., Dunbar M., McKinnon R.D. Distinct roles for PI3K in proliferation and survival of oligodendrocyte progenitor cells. J. Neurosci. Res. 2000, 62:336-345.
21. Eccleston P.A., Silberberg D.H. Fibroblast growth factor is a mitogen for oligodendrocytes in vitro. Brain Res. 1985, 353:315-318.
22. Ellison J.A., Scully S.A., de Vellis J. Evidence for neuronal regulation of oligodendrocyte development: cellular localization of platelet-derived growth factor alpha receptor and A-chain mRNA during cerebral cortex development in the rat. J. Neurosci. Res. 1996, 45:28-39.
23. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005, 16:139-149.
24. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 1998, 273:18623-18632.
25. Finzsch M., Stolt C.C., Lommes P., Wegner M. Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression. Development 2008, 135:637-646.
26. Fortin D., Rom E., Sun H., Yayon A., Bansal R. Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage. J. Neurosci. 2005, 25:7470-7479.
27. Frost E., Kiernan B.W., Faissner A., Ffrench-Constant C. Regulation of oligodendrocyte precursor migration by extracellular matrix: evidence for substrate-specific inhibition of migration by tenascin-C. Dev. Neurosci. 1996, 18:266-273.
28. Frost E.E., Buttery P.C., Milner R., Ffrench-Constant C. Integrins mediate a neuronal survival signal for oligodendrocytes. Curr. Biol. 1999, 9:1251-1254.
29. Frost E.E., Milner R., Ffrench-Constant C. Migration assays for oligodendrocyte precursor cells. Extracellular Matrix Protocols. Methods in Molecular Biology 2000, vol. 139:265-278. Humana Press, Totowa, NJ.
30. Frost E.E., Nielsen J.A., Le T.Q., Armstrong R.C. PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J. Neurobiol. 2003, 54:457-472.
31. Frost E.E., Zhou Z., Krasnesky K., Armstrong R.C. Initiation of oligodendrocyte progenitor cell migration by a PDGF-A activated extracellular regulated kinase (ERK) signaling pathway. Neurochem. Res. 2009, 34:169-181.
32. Fruttiger M., Karlsson L., Hall A.C., Abramsson A., Calver A.R., Bostrom H., Willetts K., Bertold C.H., Heath J.K., Betsholtz C., Richardson W.D. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 1999, 126:457-467.
33. Gallo V., Zhou J.M., McBain C.J., Wright P., Knutson P.L., Armstrong R.C. Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J. Neurosci. 1996, 16:2659-2670.
34. Gard A.L., Pfeiffer S.E. Glial cell mitogens bFGF and PDGF differentially regulate development of O4+GalC-oligodendrocyte progenitors. Dev. Biol. 1993, 159:618-630.
35. Hadari Y.R., Gotoh N., Kouhara H., Lax I., Schlessinger J. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:8578-8583.
36. Haines J.D., Fragoso G., Hossain S., Mushynski W.E., Almazan G. p38 mitogen-activated protein kinase regulates myelination. J. Mol. Neurosci. 2008, 35:23-33.
37. Hatano N., Mori Y., Oh-hora M., Kosugi A., Fujikawa T., Nakai N., Niwa H., Miyazaki J., Hamaoka T., Ogata M. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 2003, 8:847-856.
38. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999, 79:1283-1316.
39. Heldin C.H., Ericsson J. Signal transduction. RIPping tyrosine kinase receptors apart. Science 2001, 294:2111-2113.
40. Kanda S., Hodgkin M.N., Woodfield R.J., Wakelam M.J., Thomas G., Claesson-Welsh L. Phosphatidylinositol 3′-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells. J. Biol. Chem. 1997, 272:23347-23353.
41. Klint P., Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front. Biosci. 1999, 4:D165-D177.
42. Lachapelle F., Avellana-Adalid V., Nait-Oumesmar B., Baron-Van Evercooren A. Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol. Cell. Neurosci. 2002, 20:390-403.
43. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
44. Levison S.W., Goldman J.E. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 1993, 10:201-212.
45. Li L., Schatteman G.C., Oppenheim R.W., Lei M., Bowen-Pope D.F., Houenou L.J. Altered development of spinal cord in the mouse mutant (Patch) lacking the PDGF receptor alpha-subunit gene. Brain Res. Dev. Brain Res. 1996, 96:204-209.
46. McKinnon R.D., Matsui T., Dubois-Dalcq M., Aaronson S.A. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 1990, 5:603-614.
47. McKinnon R.D., Smith C., Behar T., Smith T., Dubois-Dalcq M. Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells. Glia 1993, 7:245-254.
48. Miller D.L., Ortega S., Bashayan O., Basch R., Basilico C. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol. Cell. Biol. 2000, 20:2260-2268.
49. Milner R., Ffrench-Constant C. A developmental analysis of oligodendroglial integrins in primary cells: changes in alpha v-associated beta subunits during differentiation. Development 1994, 120:3497-3506.
50. Milner R., Anderson H.J., Rippon R.F., McKay J.S., Franklin R.J., Marchionni M.A., Reynolds R., Ffrench-Constant C. Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration. Glia 1997, 19:85-90.
51. Mohammadi M., Dionne C.A., Li W., Li N., Spivak T., Honegger A.M., Jaye M., Schlessinger J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 1992, 358:681-684.
52. Murtie J.C., Zhou Y.-X., Le T.Q., Armstrong R.C. In vivo analysis of oligodendrocyte lineage development in postnatal FGF2 null mice. Glia 2005, 49:542-554.
53. Newton R., Cambridge L., Hart L.A., Stevens D.A., Lindsay M.A., Barnes P.J. The MAP kinase inhibitors, PD098059, U0126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes. Br. J. Pharmacol. 2000, 130:1353-1361.
54. Pages G., Pouyssegur J. Study of MAPK signaling using knockout mice. Methods Mol. Biol. 2004, 250:155-166.
55. Pellegrino M.J., Stork P.J.S. Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells. J. Neurochem. 2006, 99:1480-1493.
56. Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 2000, 7:165-197.
57. Raballo R., Rhee J., Lyn-Cook R., Leckman J.F., Schwartz M.L., Vaccarino F.M. Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J. Neurosci. 2000, 20:5012-5023.
58. Rakic S., Zecevic N. Early oligodendrocyte progenitor cells in the human fetal telencephalon. Glia 2003, 41:117-127.
59. Richardson W.D., Pringle N., Mosley M.J., Westermark B., Dubois-Dalcq M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 1988, 53:309-319.
60. Saba-El-Leil M.K., Vella F.D., Vernay B., Voisin L., Chen L., Labrecque N., Ang S.L., Meloche S. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep. 2003, 4:964-968.
61. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000, 103:211-225.
62. Smith E.A., Seldin M.F., Martinez L., Watson M.L., Choudhury G.G., Lalley P.A., Pierce J., Aaronson S., Barker J., Naylor S.L., et al. Mouse platelet-derived growth factor receptor alpha gene is deleted in W19H and patch mutations on chromosome 5. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:4811-4815.
63. Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 1997, 124:2691-2700.
64. Sorkin A., Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell. Biol. 2002, 3:600-614.
65. Spassky N., de Castro F., Le Bras B., Heydon K., Queraud-LeSaux F., Bloch-Gallego E., Chedotal A., Zalc B., Thomas J.L. Directional guidance of oligodendroglial migration by class 3 semaphorins and netrin-1. J. Neurosci. 2002, 22:5992-6004.
66. Stariha R.L., Kikuchi S., Siow Y.L., Pelech S.L., Kim M., Kim S.U. Role of extracellular signal-regulated protein kinases 1 and 2 in oligodendroglial process extension. J. Neurochem. 1997, 68:945-953.
67. Stork P.J. ERK signaling: duration, duration, duration. Cell Cycle 2002, 1:315-317.
68. Tsai H.H., Frost E., To V., Robinson S., Ffrench-Constant C., Geertman R., Ransohoff R.M., Miller R.H. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 2002, 110:373-383.
69. Tsai H.H., Tessier-Lavigne M., Miller R.H. Netrin 1 mediates spinal cord oligodendrocyte precursor dispersal. Development 2003, 130:2095-2105.
70. Tsiftsoglou A.S., Vizirianakis I.S., Strouboulis J. Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 2009, 61:800-830.
71. Vaccarino F.M., Schwartz M.L., Raballo R., Nilsen J., Rhee J., Zhou M., Doetschman T., Coffin J.D., Wyland J.J., Hung Y.T. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat. Neurosci. 1999, 2:246-253.
72. van Heyningen P., Calver A.R., Richardson W.D. Control of progenitor cell number by mitogen supply and demand. Curr. Biol. 2001, 11:232-241.
73. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr. Res. 2001, 50:553-562.
74. Wolswijk G., Noble M. Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. J. Cell Biol. 1992, 118:889-900.
75. Yao Y., Li W., Wu J., Germann U.A., Su M.S., Kuida K., Boucher D.M. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:12759-12764.